Institute of Biomedical Research Corp.
Other OTCTotal Valuation
Institute of Biomedical Research Corp. carries a market capitalization of 3.30M, placing it among publicly traded companies globally.
| Market Cap | 3.30M |
| Enterprise Value | N/A |
Share Statistics
Institute of Biomedical Research Corp. currently has 66.28M shares outstanding.
| Shares Outstanding | 66.28M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -3.17 |
| P/TBV Ratio | -433.26 |
| P/FCF Ratio | -1,188.62 |
| P/OCF Ratio | -1,188.62 |
Financial Position
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -7.14 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -13,803.95 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Institute of Biomedical Research Corp.'s stock has declined approximately -90.25974% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -90.25974% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -689,305.00, while operating income came in at -52.39M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -52.39M |
| Pretax Income | -50.33M |
| Net Income | -50.33M |
| EBITDA | -689,305.00 |
| EBIT | -52.39M |
| Earnings Per Share (EPS) | -0.84 |
Balance Sheet
Total book value stands at -56.81M, with working capital of -461,331.00 providing operational flexibility.
| Cash & Cash Equivalents | N/A |
| Total Debt | N/A |
| Net Debt | 461,331.00 |
| Equity (Book Value) | -56.81M |
| Book Value Per Share | -0.95 |
| Working Capital | -461,331.00 |
Cash Flow
Institute of Biomedical Research Corp. produced -151,594.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -151,594.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -151,594.00 |
| FCF Per Share | 0.00 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.09 |
| FCF Yield | -0.08 |
Stock Splits
Institute of Biomedical Research Corp.'s most recent stock split took place on April 28, 2014 with a 10:1 split ratio.
| Last Split Date | 4/28/2014 |
| Split Ratio | 10:1 |
Scores
Institute of Biomedical Research Corp. posts an Altman Z-Score of -5,353.12, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -5,353.12 |